Davenport & CO LLC Forte Biosciences, Inc. Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Oct 14, 2021	SELL	$2.96 - $36.67 $93,536 - $1.16 Million	-31,600 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$25.01 - $40.24 $300,120 - $482,880	12,000 Added 61.22%	31,600 $1.08 Million
Q4 2020 Jan 13, 2021	SELL	$28.66 - $46.79 $206,352 - $336,888	-7,200 Reduced 26.87%	19,600 $714,000
Q3 2020 Oct 15, 2020	BUY	$14.71 - $50.69 $394,228 - $1.36 Million	26,800 New	26,800 $1.3 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.